Open Orphan

Open Orphan
Open Orphan
Open Orphan is a specialist CRO pharmaceuticals services company testing vaccines and antivirals through the use of human challenge clinical trials.
Life Science, Pharmaceutical
Between €5 million-€10 million

Articles about Open Orphan:

💡 You’re a corporate or investor and looking for startups that are innovating in the same market as Open Orphan? We’re happy to assist you with our Startup Sourcing service.